The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Clinical pharmacology and pharmacogenetics of thiopurines
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
Weinshilboum, R. M., & Sladek, S. L. (1980) · PubMed · Cited by 1,195
Management of Crohn's Disease in Adults
Lichtenstein, G. R., Hanauer, S. B., & Sandborn, W. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.168 · Cited by 1,173
Treatment of Crohn's Disease with 6-Mercaptopurine: A Long-Term, Randomized, Double-Blind Study
Present, D. H., Korelitz, B. I., Wisch, N., Glass, J. L., Sachar, D. B., & Pasternack, B. S. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005013021801 · Cited by 1,042
Dubinsky, M. C., Lamothe, S., Yang, H. Y., Targan, S. R., Sinnett, D., Théorêt, Y., & Seidman, E. G. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70140-5 · Cited by 996
Azathioprine and 6-Mercaptopurine in Crohn Disease: A Meta-Analysis
Pearson, D. C., May, G. R., Fick, G. H., & Sutherland, L. R. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-2-199507150-00009 · Cited by 950
Tiede, I., Fritz, G., Strand, S., Poppe, D., Dvorsky, R., Strand, D., Lehr, H. A., Wirtz, S., Becker, C., Atreya, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16432 · Cited by 828
Yates, C. R., Krynetski, E. Y., Loennechen, T., Fessing, M. Y., Tai, H.-L., Pui, C.-H., Relling, M. V., & Evans, W. E. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-8-199704150-00003 · Cited by 756
Relling, M. V., Hancock, M. L., Rivera, G. K., Sandlund, J. T., Ribeiro, R. C., Krynetski, E. Y., Pui, C.-H., & Evans, W. E. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.23.2001 · Cited by 733
The purine path to chemotherapy
Elion, G. B. (1989) · Science · doi:10.1126/science.2649979 · Cited by 687
Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
Lennard, L., Lilleyman, J. S., Van Loon, J., & Weinshilboum, R. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)91745-v · Cited by 651
The clinical pharmacology of 6-mercaptopurine
Lennard, L. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02220605 · Cited by 647
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
Prefontaine, E., MacDonald, J. K., & Sutherland, L. R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000545.pub3 · Cited by 604
Weinshilboum, R. M., Otterness, D. M., & Szumlanski, C. L. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.19 · Cited by 549
Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.
Connell, W. R., Kamm, M. A., Ritchie, J. K., & Lennard-Jones, J. E. (1993) · Gut · doi:10.1136/gut.34.8.1081 · Cited by 510
Dubinsky, M. C., Yang, H., Hassard, P. V., Seidman, E. G., Kam, L. Y., Abreu, M. T., Targan, S. R., & Vasiliauskas, E. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.32420 · Cited by 483
McLeod, H., Krynetski, E., Relling, M., & Evans, W. (2000) · Leukemia · doi:10.1038/sj.leu.2401723 · Cited by 437
Role of Postreplicative DNA Mismatch Repair in the Cytotoxic Action of Thioguanine
Swann, P. F., Waters, T. R., Moulton, D. C., Xu, Y.-Z., Zheng, Q., Edwards, M., & Mace, R. (1996) · Science · doi:10.1126/science.273.5278.1109 · Cited by 408
Evans, W. E., Hon, Y. Y., Bomgaars, L., Coutre, S., Holdsworth, M., Janco, R., Kalwinsky, D., Keller, F., Khatib, Z., Margolin, J., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2293 · Cited by 400
Evans, W. E., Horner, M., Chu, Y. Q., Kalwinsky, D., & Roberts, W. M. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83063-x · Cited by 392
Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms*
Otterness, D., Szumlanski, C., Lennard, L., Klemetsdal, B., Aarbakke, J., Park-Hah, J. O., Iven, H., Schmiegelow, K., Branum, E., O'Brien, J., et al. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90152-1 · Cited by 390
A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn’s disease
Plevy, S. E., Landers, C. J., Prehn, J., Carramanzana, N. M., Deem, R. L., Shealy, D., & Targan, S. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.12.6276 · Cited by 385
Collie-Duguid, E. S. R., Pritchard, Powrie, Sludden, J., Collier, Li, T., & McLeod, H. L. (1999) · Pharmacogenetics · doi:10.1097/00008571-199902000-00006 · Cited by 368
A comparison of the specificities of xanthine oxidase and aldehyde oxidase
Krenitsky, T. A., Neil, S. M., Elion, G. B., & Hitchings, G. H. (1972) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(72)90078-1 · Cited by 341
Human erythrocyte thiopurine methyltransferase: Radiochemical microassay and biochemical properties
Weinshilboum, R. M., Raymond, F. A., & Pazmiño, P. A. (1978) · Clinica Chimica Acta · doi:10.1016/0009-8981(78)90311-x · Cited by 339
Breese, E. J., Braegger, C., Corrigan, C. J., Walker-Smith, J. A., & MacDonald, T. T. (1993) · PubMed Central · Cited by 327
Marinaki, A. M., Ansari, A., Duley, J. A., Arenas, M., Sumi, S., Lewis, C. M., Shobowale-Bakre, E.-M., Escuredo, E., Fairbanks, L. D., & Sanderson, J. D. (2004) · Pharmacogenetics · doi:10.1097/00008571-200403000-00006 · Cited by 323
Krynetski, E. Y., Schuetz, J. D., Galpin, A. J., Pui, C. H., Relling, M. V., & Evans, W. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.949 · Cited by 306
Inflammatory bowel disease is not associated with an increased risk of lymphoma
Lewis, J. D., Bilker, W. B., Brensinger, C., Deren, J. J., Vaughn, D. J., & Strom, B. L. (2001) · Gastroenterology · doi:10.1053/gast.2001.28703 · Cited by 296
The thiopurine S-methyltransferase gene locus – implications for clinical pharmacogenomics
McLeod, H. L., & Siva, C. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.1.89 · Cited by 296
Dayharsh, G. A., Loftus, E. V., Sandborn, W. J., Tremaine, W. J., Zinsmeister, A. R., Witzig, T. E., Macon, W. R., & Burgart, L. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.30328 · Cited by 275
Polymorphism of the thiopurine S-methyltransferase gene in African- Americans
Hon, Y. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.2.371 · Cited by 271
Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase.
Weinshilboum, R. M. (2001) · PubMed · Cited by 269
Boirivant, M., Marini, M., Di Felice, G., Pronio, A. M., Montesani, C., Tersigni, R., & Strober, W. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70177-0 · Cited by 268
Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency
Sumi, S., Marinaki, A., Arenas, M., Fairbanks, L., Shobowale-Bakre, M., Rees, D., Thein, S., Ansari, A., Sanderson, J., De Abreu, R., et al. (2002) · Human Genetics · doi:10.1007/s00439-002-0798-z · Cited by 267
Management of Crohn's disease in adults
Hanauer, S. B., Sandborn, W., & The Practice Parameters Committee of the American College of Gastroenterology (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03671.x · Cited by 261
Tai, H.-L., Krynetski, E. Y., Schuetz, E. G., Yanishevski, Y., & Evans, W. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6444 · Cited by 259
Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy
Wollner, N., Burchenal, J. H., Lieberman, P. H., Exelby, P., D'Angio, G., & Murphy, M. L. (1976) · Cancer · doi:10.1002/1097-0142(197601)37:1<123::aid-cncr2820370119>3.0.co;2-7 · Cited by 250
Inflammatory Bowel Disease Is Not Associated With An Increased Risk Of Lymphoma
&NA; (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200112000-00025 · Cited by 250
Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia.
Lennard, L., & Lilleyman, J. S. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.12.1816 · Cited by 244
Thiopurine methyltransferase alleles in British and Ghanaian populations
Ameyaw, M. M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.2.367 · Cited by 240
Sandborn, W. J., Tremaine, W. J., Wolf, D. C., Targan, S. R., Sninsky, C. A., Sutherland, L. R., Hanauer, S. B., McDonald, J. W. D., Feagan, B. G., Fedorak, R. N., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70445-2 · Cited by 237
Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease
Kirschner, B. S. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70251-3 · Cited by 234
Controlled trial of azathioprine in chronic ulcerative colitis.
Kirk, A. P., & Lennard-Jones, J. E. (1982) · BMJ · doi:10.1136/bmj.284.6325.1291 · Cited by 228
Szumlanski, C., & Weinshilboum, R. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04478.x · Cited by 223
Schütz, E., Gummert, J., Mohr, F., & Oellerich, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)93028-y · Cited by 222
Veerman, A. J., Hählen, K., Kamps, W. A., Van Leeuwen, E. F., De Vaan, G. A., Solbu, G., Suciu, S., Van Wering, E. R., & Van der Does-Van der Berg, A. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.911 · Cited by 204
Pharmacogenetics of Thiopurine S-Methyltransferase and Thiopurine Therapy
Evans, W. E. (2004) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200404000-00018 · Cited by 203
Zimm, S., Collins, J. M., O'Neill, D., Chabner, B. A., & Poplack, D. G. (1983) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1983.254 · Cited by 173
Risk of lymphoma in inflammatory bowel disease
Loftus, E. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01108-4 · Cited by 173
Chocair, P. R., Duley, J. A., Simmonds, H. A., & Cameron, J. S. (1992) · Transplantation · doi:10.1097/00007890-199205000-00016 · Cited by 169
Review article: thiopurines in inflammatory bowel disease
DERIJKS, L. J. J., GILISSEN, L. P. L., HOOYMANS, P. M., & HOMMES, D. W. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02980.x · Cited by 161
Teml, A., Schaeffeler, E., Herrlinger, K. R., Klotz, U., & Schwab, M. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746030-00001 · Cited by 159
Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR‐1 in the Egyptian population
Hamdy, S. I., Hiratsuka, M., Narahara, K., Endo, N., El‐Enany, M. M., Moursi, N., Ahmed, M. S. ‐., & Mizugaki, M. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01786.x · Cited by 159
Handbook of cancer chemotherapy
(1993) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(93)90321-b · Cited by 158
Non‐Hodgkin's lymphoma in children
Wollner, N., Burchenal, J. H., LIEBERMAN, P. H., et al. (1975) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950010307 · Cited by 157
Olsalazine and 6-mercaptopurine-related bone marrow suppression: A possible drug-drug interaction
Lewis, L. D., Benin, A., Szumlanski, C. L., et al. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90125-9 · Cited by 156
THE FATE OF 6‐MERCAPTOPURINE IN MICE
Elion, G. B., Bieber, S., & Hitchings, G. H. (1954) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1954.tb40020.x · Cited by 153
Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.
Elion, G. B. (1967) · PubMed · Cited by 150
Krynetski, E. Y., & Evans, W. E. (1999) · Pharmaceutical Research · doi:10.1023/a:1011909315614 · Cited by 136
Human kidney thiopurine methyltransferase purification and biochemical properties
Woodson, L. C., & Weinshilboum, R. M. (1983) · Biochemical Pharmacology · doi:10.1016/0006-2952(83)90582-8 · Cited by 133
Tai, H.-L., Fessing, M. Y., Bonten, E. J., Yanishevsky, Y., d’Azzo, A., Krynetski, E. Y., & Evans, W. E. (1999) · Pharmacogenetics and Genomics · doi:10.1097/01213011-199910000-00011 · Cited by 132
Thomas, C. W., Myhre, G. M., Tschumper, R. C., Raghavakaimal, S., Jelinek, D. F., McKEAN, D. J., Lipsky, J. J., Sandborn, W. J., & Egan, L. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.074815 · Cited by 132
THE TREATMENT OF CHRONIC ULCERATIVE COLITIS WITH 6‐MERCAPTOPURINE
Bean, R. H. D. (1962) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1962.tb20590.x · Cited by 130
Thiopurine methyltransferase polymorphic tandem repeat: Genotype-phenotype correlation analysis
Li, Y. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.108674 · Cited by 127
Otterness, D. M., Szumlanski, C. L., Wood, T. C., & Weinshilboum, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1004 · Cited by 125
Chan, G. L. C., Erdmann, G. R., Gruber, S. A., Matas, A. J., & Canafax, D. M. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb03606.x · Cited by 120
RELATIONSHIP BETWEEN METABOLIC FATES AND ANTITUMOR ACTIVITIES OF THIOPURINES.
Elion, G. B., CALLAHAN, S., Rw, R., et al. (1963) · PubMed · Cited by 117
Thiopurine methyltransferase. Aromatic thiol substrates and inhibition by benzoic acid derivatives.
Woodson, L. C., Ames, M. M., Selassie, C. D., Hänsch, C., & Weinshilboum, R. M. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14466-0 · Cited by 113
xAzathioprine therapy for patients with systemic lupus erythematosus
Abu‐Shakra, M., & Shoenfeld, Y. (2001) · Lupus · doi:10.1191/096120301676669495 · Cited by 104
Pratt, D., Flavin, D., & Kaplan, M. M. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536867 · Cited by 98
Breast-Feeding During Maternal Use of Azathioprine
Moretti, M. E., Verjee, Z. H., Ito, S., & Koren, G. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h152 · Cited by 94
Drug interaction between infliximab and azathioprine in patients with Crohn's disease
Roblin, X., Serre-Debeauvais, F., Phelip, J., Bessard, G., & Bonaz, B. L. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01778.x · Cited by 93
Tay, B. S. J., Lilley, R. M., Murray, A., & Atkinson, M. R. (1969) · Biochemical Pharmacology · doi:10.1016/0006-2952(69)90069-0 · Cited by 93
Mori, S., Ohtsuki, S., Takanaga, H., Kikkawa, T., Kang, Y., & Terasaki, T. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02552.x · Cited by 90
Langley, P. G., Underhill, J. A., Tredger, J. M., Norris, S., & McFarlane, I. G. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00214-3 · Cited by 89
THE FATE OF 6‐MERCAPTOPURINE IN MAN
Hamilton, L. D., & Elion, G. B. (1954) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1954.tb40021.x · Cited by 89
Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients
Goßmann, J., Thürmann, P., Bachmann, T., Weller, S., Kachel, H.-G., Schoeppe, W., & Scheuermann, E.-H. (1996) · Kidney International · doi:10.1038/ki.1996.398 · Cited by 84
de la Moureyre, C. S., Debuysère, H., Fazio, F., Sergent, E., Bernard, C., Sabbagh, N., Marez, D., Lo‐Guidice, J., D'Halluin, J.-C., & Broly, F. (1999) · PubMed · Cited by 82
Identification of two novel sequence variants affecting thiopurine methyltransferase enzyme activity
Appell, M. L., Haglund, S., Almer, S. H., Peterson, C. O., Taipalensuu, J., Hertervig, E., s, E. L., & S�derkvist, P. (2004) · Pharmacogenetics · doi:10.1097/00008571-200404000-00006 · Cited by 78
Alves, S. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117284 · Cited by 75
Goßmann, J., Kachel, H.-G., Schoeppe, W., & Scheuermann, E. H. (1993) · Transplantation · doi:10.1097/00007890-199309000-00018 · Cited by 71
Interethnic difference in thiopurine methyltransferase activity
Klemetsdal, B., Tollefsen, E., Loennechen, T., Johnsen, K., Utsi, E., Gisholt, K., Wist, E., & Aarbakke, J. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.4 · Cited by 69
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
Sandborn, W. J., Sutherland, L. R., Pearson, D. C., May, G. R., Modigliani, R., & Prantera, C. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000545 · Cited by 69
Marinaki, A. M., Arenas, M., Khan, Z. H., Lewis, C. M., Shobowale–Bakre, E.-M., Escuredo, E., Fairbanks, L. D., Mayberry, J. F., Wicks, A. C., Ansari, A. R., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200302000-00006 · Cited by 53
Hamdan-Khalil, R., Allorge, D., Lo‐Guidice, J., Cauffiez, C., Chevalier, D., Spire, C., Houdret, N., Libersa, C., Lhermitte, M., Colombel, J., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.103 · Cited by 52
Murphy, L., & Atherton, D. J. (2003) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2003.20617.x · Cited by 43
Shepherd, P. C. A., Fooks, J., Gray, R. G., & Allan, N. C. (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb04520.x · Cited by 41
Cripe, L. D. (1997) · Current Problems in Cancer · doi:10.1016/s0147-0272(97)80006-2 · Cited by 37
Intravenous Azathioprine in Severe Ulcerative Colitis: A Pilot Study
Mahadevan, U., Tremaine, W. J., Johnson, T., et al. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03362.x · Cited by 35
Clinical pharmacology of inflammatory bowel disease therapies
Sandborn, W. J., & Faubion, W. A. (2000) · Current Gastroenterology Reports · doi:10.1007/s11894-000-0005-0 · Cited by 28
Kitchen, B. J., Moser, A. M., Lowe, E., Balis, F. M., Widemann, B. C., Anderson, L. W., Strong, J., Blaney, S. M., Berg, S. L., O’Brien, M., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35178-x · Cited by 27
Jacobs, S. S., Stork, L. C., Bostrom, B., Hutchinson, R., Holcenberg, J. S., Reaman, G. H., Erdmann, G. R., Franklin, J. L., Neglia, J. P., Steinberg, S. M., et al. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20964 · Cited by 27
Thiopurine S-methyltransferase as a target for drug interactions
Xin, H., Fischer, C., Schwab, M. G., & Klotz, U. E. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0950-5 · Cited by 25
Konits, P. H., Egorin, M. J., Echo, D. A. V., et al. (1982) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00255484 · Cited by 23
Diminished Anticoagulant Effects of Warfarin with Concomitant Mercaptopurine Therapy
Martin, L. A., & Mehta, S. D. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.2.260.32080 · Cited by 14
Cited by
Mack, C. L., Adams, D., Assis, D. N., Kerkar, N., Manns, M. P., Mayo, M. J., Vierling, J. M., Alsawas, M., Murad, M. H., & Czaja, A. J. (2020) · Hepatology · doi:10.1002/hep.31065 · Cited by 983
“5% of the normal population,(281-284) but the possibility of preventing severe bone marrow toxicity may warrant its use without an analysis of cost-effectiveness.”
BackgroundSinglet Molecular Oxygen Reactions with Nucleic Acids, Lipids, and Proteins
Di Mascio, P., Martinez, G. R., Miyamoto, S., Ronsein, G. E., Medeiros, M. H. G., & Cadet, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00554 · Cited by 659
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
Prefontaine, E., MacDonald, J. K., & Sutherland, L. R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000545.pub3 · Cited by 604
A New View into the Regulation of Purine Metabolism: The Purinosome
Pedley, A. M., & Benkovic, S. J. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.09.009 · Cited by 576
Kucharzik, T., Ellul, P., Greuter, T., Rahier, J. F., Verstockt, B., Abreu, C., Albuquerque, A., Allocca, M., Esteve, M., Farraye, F. A., et al. (2021) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjab052 · Cited by 480
Metadata
- Authors
- Sahasranaman, S., Howard, D., & Roy, S.
- Venue
- European Journal of Clinical Pharmacology
- Published
- 2008-05-28
- Volume
- 64
- Issue
- 8
- Pages
- 753-767
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W2095027842
- Cited by
- 405
- References
- 96
- FWCI
- 17.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.